Skip to main content

Table 1 Patient characteristics

From: Modified endoscopic transnasal orbital apex decompression in dysthyroid optic neuropathy

Characteristics

N = 42

Female (%)

18 (43)

Age (years)

57.30 ± 9.29

BMI (kg/m2)

24.40 ± 2.71

Follow up time (months)

6 (2–8)

Medical background

 Diabetes (%)

6 (14)

 Hypertension (%)

15(36)

Thyroid

 Hyperthyroidism (%)

38 (90)

 Hypothyroidism (%)

1 (2)

 Normal (%)

3 (7)

 Duration of Thyroid dysfunction (months)

12 (7.75–36)

 Duration of TAO (months)

10.5 (6–12)

 Duration of DON (months)

6 (2–11)

Serum

 FT3 (pg/ml)

5.27 (4.44–5.94)

 FT4 (ng/dl)

17.25 (13.5–20.94)

 TSH (μIU/ml)

0.94 (0.08–3.78)

 TG (ng/ml)

43.47 (10.44–181)

 TGAb (IU/ml)

12.05 (10–18.44)

 TPOAb (IU/ml)

21.55 (11.32–56.16)

  1. BMI= body mass index, TAO= thyroid associated ophthalmopathy, DON= dysthyroid optic neuropathy, FT3= free triiodothyronine, FT4= free thyroxinem, TSH= thyroid stimulating hormone, TG= thyroglobulin, TGAb= thyroglobulin antibody, TPOAb= thyroid peroxidase antibody